1
|
Kusano S, Ueda S, Oryoji D, Toyoumi A, Hashimoto-Tane A, Kishi H, Hamana H, Muraguchi A, Jin H, Arase H, Miyadera H, Kishikawa R, Yoshikai Y, Yamada H, Yamamoto K, Nishimura Y, Saito T, Sasazuki T, Yokoyama S. Contributions of the N-terminal flanking residues of an antigenic peptide from the Japanese cedar pollen allergen Cry j 1 to the T-cell activation by HLA-DP5. Int Immunol 2023; 35:447-458. [PMID: 37418020 PMCID: PMC10478803 DOI: 10.1093/intimm/dxad024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2022] [Accepted: 06/05/2023] [Indexed: 07/08/2023] Open
Abstract
Cry j 1 is a major allergen present in Japanese cedar (Cryptomeria japonica) pollens. Peptides with the core sequence of KVTVAFNQF from Cry j 1 ('pCj1') bind to HLA-DP5 and activate Th2 cells. In this study, we noticed that Ser and Lys at positions -2 and -3, respectively, in the N-terminal flanking (NF) region to pCj1 are conserved well in HLA-DP5-binding allergen peptides. A competitive binding assay showed that the double mutation of Ser(-2) and Lys(-3) to Glu [S(P-2)E/K(P-3)E] in a 13-residue Cry j 1 peptide (NF-pCj1) decreased its affinity for HLA-DP5 by about 2-fold. Similarly, this double mutation reduced, by about 2-fold, the amount of NF-pCj1 presented on the surface of mouse antigen-presenting dendritic cell line 1 (mDC1) cells stably expressing HLA-DP5. We established NF-pCj1-specific and HLA-DP5-restricted CD4+ T-cell clones from HLA-DP5 positive cedar pollinosis (CP) patients, and analyzed their IL-2 production due to the activation of mouse TG40 cells expressing the cloned T-cell receptor by the NF-pCj1-presenting mDC1 cells. The T-cell activation was actually decreased by the S(P-2)E/K(P-3)E mutation, corresponding to the reduction in the peptide presentation by this mutation. In contrast, the affinity of NF-pCj1·HLA-DP5 for the T-cell receptor was not affected by the S(P-2)E/K(P-3)E mutation, as analyzed by surface plasmon resonance. Considering the positional and side-chain differences of these NF residues from previously reported T-cell activating sequences, the mechanisms of enhanced T-cell activation by Ser(-2) and Lys(-3) of NF-pCj1 may be novel.
Collapse
Affiliation(s)
- Seisuke Kusano
- RIKEN Structural Biology Laboratory, Yokohama 230-0045, Japan
- RIKEN Cluster for Science, Technology and Innovation Hub, Yokohama 230-0045, Japan
| | - Sho Ueda
- Institute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan
| | - Daisuke Oryoji
- Institute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan
| | - Aya Toyoumi
- Institute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan
| | | | - Hiroyuki Kishi
- Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan
| | - Hiroshi Hamana
- Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan
| | - Atsushi Muraguchi
- Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan
| | - Hui Jin
- Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
| | - Hisashi Arase
- Department of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
- Laboratory of Immunochemistry, WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan
| | - Hiroko Miyadera
- Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan
- Research Institute, National Center for Global Health and Medicine, Chiba 272-8516, Japan
- Department of Medical Genetics, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
| | - Reiko Kishikawa
- Department of Allergology, The National Hospital Organization Fukuoka National Hospital, Fukuoka 811-1394, Japan
| | - Yasunobu Yoshikai
- Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
| | - Hisakata Yamada
- Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
| | - Ken Yamamoto
- Department of Medical Biochemistry, Kurume University School of Medicine, Kurume 830-0011, Japan
| | - Yasuharu Nishimura
- Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
| | - Takashi Saito
- RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan
| | - Takehiko Sasazuki
- Institute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan
| | - Shigeyuki Yokoyama
- RIKEN Structural Biology Laboratory, Yokohama 230-0045, Japan
- RIKEN Cluster for Science, Technology and Innovation Hub, Yokohama 230-0045, Japan
| |
Collapse
|